Feb 19, 2021
Luminex Receives BARDA Funding to Support Development and Validation of Test Combining SARS-CoV-2 and Flu/RSV Respiratory Panel
Feb 08, 2021
Luminex Corporation Reports Fourth Quarter and Full-Year 2020 Results
Jan 13, 2021
Luminex Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference
Jan 12, 2021
Luminex Corporation Pre-Release of 4th Quarter 2020 Revenue
Dec 16, 2020
Luminex Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference
Dec 07, 2020
Luminex Corporation Declares Fourth Quarter Cash Dividend
Nov 05, 2020
Luminex Corporation Reports Strong Third Quarter 2020 Results
Oct 07, 2020
Luminex Corporation Pre-Release of 3rd Quarter 2020 Revenue
Sep 24, 2020
Luminex Receives BARDA Award to Support 510(k) Filing for NxTAG Respiratory Pathogen Panel That Includes SARS-CoV-2
Sep 23, 2020
Luminex Receives BARDA Award to Support Enhancement of COVID-19 Multiplex Antibody Test
Sep 15, 2020
Luminex Corporation Declares Third Quarter Cash Dividend
Aug 04, 2020
Luminex Corporation Announces Departure of G. Walter Loewenbaum from Its Board of Directors
Aug 04, 2020
Luminex Corporation Reports Second Quarter 2020 Results
Jul 22, 2020
Luminex Files for Emergency Use Authorization for Expanded NxTAG Respiratory Panel Test Including SARS-CoV-2
Jul 20, 2020
Luminex Corporation Second Quarter Earnings Release Rescheduled for August 4, 2020
Jul 20, 2020
Luminex Receives FDA Emergency Use Authorization for COVID-19 Antibody Test
Jul 08, 2020
Luminex Corporation Pre-Release of 2nd Quarter 2020 Revenue
Jul 01, 2020
Luminex Delivers xMAP® INTELLIFLEX Systems to Life Science Research Partners
May 22, 2020
Luminex Corporation Declares Second Quarter Cash Dividend
May 08, 2020
Luminex Corporation Announces Pricing Of Offering Of $260 Million Of 3.00% Convertible Senior Notes Due 2025